诺如病毒
衣壳
信使核糖核酸
病毒学
转染
生物
体外
类病毒颗粒
表位
抗体
鼠诺如病毒
抗原
细胞内
HEK 293细胞
微生物学
细胞培养
急性胃肠炎
免疫系统
分子生物学
细胞
病毒
接种疫苗
细胞内寄生虫
化学
核糖核酸
细胞生物学
作者
Judith Mary Reyes Ballista,Courtney David,Amanda Pirrone,Estibaliz Fernández,Jiajie Wei,Zhiyun Wen
出处
期刊:Vaccine
[Elsevier BV]
日期:2026-10-26
卷期号:95: 129272-129272
标识
DOI:10.1016/j.vaccine.2026.129272
摘要
Human norovirus is a leading cause of acute gastroenteritis worldwide across all age groups, yet no licensed vaccine is available. The major capsid protein, VP1, self-assembles into highly immunogenic virus-like particles (VLPs) that have shown promise in clinical studies. Recently, mRNA has emerged as a compelling platform for norovirus vaccination. However, whether VP1-encoding mRNA can drive authentic VLP formation in human cells relevant to the vaccination environment has remained unknown. In this study, we used multiple human cell lines, including THP-1-derived macrophage-like cells, to model the post-vaccination environment. Transfection with norovirus GII.4 VP1 mRNA or lipid nanoparticle-formulated VP1 mRNA induced both intracellular and extracellular VP1 expression. Sucrose gradient purification and electron microscopy confirmed VLP assembly. These particles retained key antigenic and functional properties, including recognition by norovirus-specific antibodies in human serum and binding to histo-blood group antigens. Collectively, our findings provide direct evidence that VP1-encoding mRNA can generate structurally and functionally relevant norovirus VLPs in physiologically relevant human cell systems. These results strengthen the mechanistic rationale for mRNA-based norovirus vaccines and support their continued development.
科研通智能强力驱动
Strongly Powered by AbleSci AI